Papers
16
Total Citations
334
H-Index
9
About
Dr. Hiro-omi Kanayama is a pioneering Japanese urologic surgeon whose work centers on advancing robot-assisted surgery, particularly for renal and prostate cancers. His most impactful contributions involve the clinical validation of the *hinotori™* Surgical Robot System, a novel Japanese platform. In a landmark 2022 study with 106 citations, he demonstrated the safety and efficacy of this system through preclinical and clinical evaluations, establishing it as a viable alternative to established robotic platforms. Dr. Kanayama has also made seminal contributions to the debate on surgical approaches for renal hilar tumors, leading a prospective multi-institutional study (48 citations) that confirmed the superiority of robot-assisted partial nephrectomy over laparoscopic techniques. His research consistently emphasizes long-term outcomes, as seen in a multi-center study with a minimum five-year follow-up (13 citations), and he has been instrumental in national-level assessments, including the 16th National Survey of Endoscopic Surgery in Japan (17 citations). With over 300 total citations, Dr. Kanayama’s work is shaping the future of minimally invasive urologic oncology, particularly through the adoption of Japanese robotic systems and the refinement of complex nephron-sparing and cystectomy procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10